ID

19465

Descripción

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00169143

Link

https://clinicaltrials.gov/show/NCT00169143

Palabras clave

Versiones (1)
  1. 4/1/17 4/1/17 -
Subido en

4 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Untreated CD20-Positive Large B-Cell Lymphoma NCT00169143

Inglés

Eligibility Untreated CD20-Positive Large B-Cell Lymphoma NCT00169143

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with histologically proven cd20+ diffuse large b cell lymphoma (who classification).
Descripción

Diffuse Large B-Cell Lymphoma CD20 antigen positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C3888518
age >18 and < 61 years, eligible for transplant.
Descripción

Age | Transplantation eligibility

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0040732
UMLS CUI [2,2]
C1698001
patient not previously treated.
Descripción

Patient untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
with at least two prognostic factors of the aa-ipi.
Descripción

International Prognostic Index Age Adjusted | Prognostic Factor Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512894
UMLS CUI [1,2]
C0001779
UMLS CUI [1,3]
C0456081
UMLS CUI [2,1]
C1514474
UMLS CUI [2,2]
C1265611
with a minimum life expectancy of 3 months.
Descripción

Life Expectancy Minimum

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C1524031
creatinin level ≤ 150mmol/l, total bilirubin level  30mmol/l and transaminases  2.5 maximum normal level, unless abnormalities are related to the lymphoma.
Descripción

Creatinine measurement, serum | Serum total bilirubin measurement | Transaminases increased | Abnormality Lymphoma Related

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0438717
UMLS CUI [4,1]
C1704258
UMLS CUI [4,2]
C0024299
UMLS CUI [4,3]
C0439849
neutrophils > 1.5 g/l and platelets > 100 g/l, unless if patient has a bone marrow infiltration.
Descripción

Absolute neutrophil count | Platelet Count measurement | Bone marrow infiltration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C3854434
negative hiv, hbv and hcv serologies  4 weeks (except after vaccination).
Descripción

HIV test negative | Hepatitis B Virus Serology negative | Hepatitis C virus Serology negative | Vaccination

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0854048
UMLS CUI [2,1]
C0019169
UMLS CUI [2,2]
C0919674
UMLS CUI [3,1]
C0220847
UMLS CUI [3,2]
C0919674
UMLS CUI [4]
C0042196
having previously signed a written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other histological type of lymphoma.
Descripción

Lymphoma Histologic type

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0449574
any history of treated or non-treated indolent lymphoma.
Descripción

Indolent lymphoma Treated | Indolent lymphoma untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1334170
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1334170
UMLS CUI [2,2]
C0332155
central nervous system or meningeal involvement by lymphoma.
Descripción

Central Nervous System Involvement Lymphoma | Meningeal Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0024299
UMLS CUI [2]
C2213017
contra-indication to any drug contained in the chemotherapy regimens.
Descripción

Medical contraindication Antineoplastic Agents

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0003392
any history of cancer during the last 5 years, with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
Descripción

Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
UMLS CUI [3]
C0851140
any serious active disease (according to the investigator’s decision).
Descripción

Disease Serious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
Descripción

Investigational New Drugs | Chemotherapy cycle Ordinal number

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2,1]
C1302181
UMLS CUI [2,2]
C0439080
pregnant or lactating women or women of childbearing potential not currently practicing an adequate method of contraception.
Descripción

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Inadequate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0205412
adult patient under tutelage.
Descripción

Patient adult Guardianship

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0001675
UMLS CUI [1,3]
C0870627
Volver a la parte superior de la página

Similar models

Eligibility Untreated CD20-Positive Large B-Cell Lymphoma NCT00169143

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse Large B-Cell Lymphoma CD20 antigen positive
Item
patient with histologically proven cd20+ diffuse large b cell lymphoma (who classification).
boolean
C0079744 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
Age | Transplantation eligibility
Item
age >18 and < 61 years, eligible for transplant.
boolean
C0001779 (UMLS CUI [1])
C0040732 (UMLS CUI [2,1])
C1698001 (UMLS CUI [2,2])
Patient untreated
Item
patient not previously treated.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
International Prognostic Index Age Adjusted | Prognostic Factor Quantity
Item
with at least two prognostic factors of the aa-ipi.
boolean
C1512894 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0456081 (UMLS CUI [1,3])
C1514474 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Life Expectancy Minimum
Item
with a minimum life expectancy of 3 months.
boolean
C0023671 (UMLS CUI [1,1])
C1524031 (UMLS CUI [1,2])
Creatinine measurement, serum | Serum total bilirubin measurement | Transaminases increased | Abnormality Lymphoma Related
Item
creatinin level ≤ 150mmol/l, total bilirubin level  30mmol/l and transaminases  2.5 maximum normal level, unless abnormalities are related to the lymphoma.
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0438717 (UMLS CUI [3])
C1704258 (UMLS CUI [4,1])
C0024299 (UMLS CUI [4,2])
C0439849 (UMLS CUI [4,3])
Absolute neutrophil count | Platelet Count measurement | Bone marrow infiltration
Item
neutrophils > 1.5 g/l and platelets > 100 g/l, unless if patient has a bone marrow infiltration.
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C3854434 (UMLS CUI [3])
HIV test negative | Hepatitis B Virus Serology negative | Hepatitis C virus Serology negative | Vaccination
Item
negative hiv, hbv and hcv serologies  4 weeks (except after vaccination).
boolean
C0854048 (UMLS CUI [1])
C0019169 (UMLS CUI [2,1])
C0919674 (UMLS CUI [2,2])
C0220847 (UMLS CUI [3,1])
C0919674 (UMLS CUI [3,2])
C0042196 (UMLS CUI [4])
Informed Consent
Item
having previously signed a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Lymphoma Histologic type
Item
any other histological type of lymphoma.
boolean
C0024299 (UMLS CUI [1,1])
C0449574 (UMLS CUI [1,2])
Indolent lymphoma Treated | Indolent lymphoma untreated
Item
any history of treated or non-treated indolent lymphoma.
boolean
C1334170 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1334170 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Central Nervous System Involvement Lymphoma | Meningeal Lymphoma
Item
central nervous system or meningeal involvement by lymphoma.
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
C2213017 (UMLS CUI [2])
Medical contraindication Antineoplastic Agents
Item
contra-indication to any drug contained in the chemotherapy regimens.
boolean
C1301624 (UMLS CUI [1,1])
C0003392 (UMLS CUI [1,2])
Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
any history of cancer during the last 5 years, with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Disease Serious
Item
any serious active disease (according to the investigator’s decision).
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Investigational New Drugs | Chemotherapy cycle Ordinal number
Item
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
boolean
C0013230 (UMLS CUI [1])
C1302181 (UMLS CUI [2,1])
C0439080 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Inadequate
Item
pregnant or lactating women or women of childbearing potential not currently practicing an adequate method of contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
Patient adult Guardianship
Item
adult patient under tutelage.
boolean
C0030705 (UMLS CUI [1,1])
C0001675 (UMLS CUI [1,2])
C0870627 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial